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Background
Use of a nebulizer facilitates rapid administration of high
doses of drug, which is desirable for patients presenting
with acute severe asthma. Breath-enhanced jet nebulizers
direct the patient’s air flow through the nebulizer handset
during inhalation producing aerosol output with a more
favorable respirable profile. SideStream Plus (SS+; Philips
Respironics) and Nebutech (NB; Salter Labs) are breath-
enhanced jet nebulizers, designed to produce a high deliv-
ered dose in a short treatment time. A previous in vitro
characterization of delivered dose and droplet size distri-
bution of arformoterol nebulized via the SS+ and the NB
indicated that the SS+ performed favorably, compared
with the NB. [1] We present results of an in vitro charac-
terization of salbutamol sulphate (albuterol sulfate) deliv-
ery via the SS+ nebulizer and the NB nebulizer.
Method
Each nebulizer was filled with 3 ml salbutamol sulphate (5
mg/2.5 ml) and run with a driving flow of 8 l/min into a
CEN adult tidal breathing pattern (Vt; 500 ml, 15 BPM, I:
E ratio; 1:1). The nebulizers were run in triplicate to sput-
ter point and sputter point plus 60 s. Dose delivered to a
filter (delivered dose; DD), placed between the nebulizer
and breathing emulator, was quantified using high perfor-
mance liquid chromatography and expressed as a µl solu-
tion equivalent. A laser diffractor (Malvern Spraytec) was
used to assess fine particle fraction (FPF) and mass median
diameter (MMD) after 60 s nebulization time. Fine particle
dose (FPD) was calculated (FPF x delivered dose).
Results
The results are shown in Table 1.
Conclusion
The total DD from the 2 nebulizers was comparable. Aero-
sol delivered via the SS+ nebulizer had a lower MMD and
higher FPF, compared with that delivered via the NB nebu-
lizer. This resulted in a 74% higher FPD delivered to sput-
ter, and a 55% higher FPD delivered to sputter plus 60 s
from the SS+ nebulizer compared with the NB nebulizer.
The FPD represents respirable aerosol, and is therefore
more clinically relevant than the DD. These results are con-
sistent with previous work, and indicate that a high respir-
able dose of aerosol is produced by the SS+ nebulizer [1].
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Table 1
Experimental parameter SS+ NB
MMD (µm) 3.2 5.6
FPF (%<5 µm) 74.2 43.7
DD; Sputter (µl solution) 432 424
FPD; Sputter (µl solution) 321 185
DD; Sputter + 60 s (µl solution) 542 594
FPD; Sputter + 60 s (µl solution) 402 260
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